PMID: 3760276Sep 1, 1986Paper

Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris

Journal of the American Academy of Dermatology
J E BernsteinH H Roenigk

Abstract

Alterations in the cutaneous vascular system are prominent in psoriasis and may play an important role in the pathogenesis of this disorder. We evaluated the effects of topically applied capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide), a known inhibitor of cutaneous vasodilatation, on moderate and severe psoriasis. Under a double-blind paradigm, forty-four patients with symmetrically distributed psoriatic lesions applied topical capsaicin to one side of their body and identical-appearing vehicle to the other side for 6 weeks. After 3 and 6 weeks of treatment, we performed ratings on changes in scaling and erythema, as well as overall improvement of the psoriasis. Over the course of the study, significantly greater overall improvement was observed on sides treated with capsaicin compared to sides treated with vehicle. Similarly, significantly greater reductions in scaling and erythema accompanied capsaicin application. Burning, stinging, itching, and redness of the skin were noted by nearly half of the patients on initial applications of study medication but diminished or vanished upon continued application. These results suggest that topical application of capsaicin may be a useful new approach in the treatment of psoriasis.

References

Feb 1, 1986·Journal of the American Academy of Dermatology·E M FarberJ E Fraki
Feb 1, 1972·Archives of Dermatology·I M BravermanE O'Keefe
Sep 1, 1967·British Journal of Pharmacology and Chemotherapy·N JancsóJ Szolcsányi
Aug 1, 1960·Archives of Dermatology·J C LAWLER, W R VINEYARD

❮ Previous
Next ❯

Citations

Jan 1, 2000·Archives of Pharmacal Research·D H KimW B Kim
Aug 23, 2008·Archives of Dermatological Research·Ilkka T HarvimaAnita Naukkarinen
Sep 5, 1995·European Journal of Pharmacology·A AhluwaliaR J Flower
Apr 1, 1991·Journal of the Autonomic Nervous System·C A Maggi
Aug 1, 1990·Trends in Pharmacological Sciences·S Bevan, J Szolcsányi
May 1, 1993·General Pharmacology·J Donnerer, R Amann
Jun 9, 2000·Clinical and Experimental Dermatology·C M NeessK Scharffetter-Kochanek
Mar 5, 1999·International Journal of Dermatology·M Lebwohl
Mar 2, 1995·The New England Journal of Medicine·M W Greaves, G D Weinstein
Feb 24, 2001·Mediators of Inflammation·C VieiraS Manzini
Jul 1, 1998·The Clinical Journal of Pain·M HautkappeA M Ostermeier
Jan 20, 2005·The British Journal of Dermatology·T JosephP S Friedmann
Sep 1, 1995·Clinical and Experimental Dermatology·M S Al'AbadieD J Gawkrodger
Aug 1, 1992·International Journal of Dermatology·B KumarE M Farber
May 1, 1994·International Journal of Dermatology·W GlinskiD Kowalski
May 1, 1994·International Journal of Dermatology·A NaukkarinenM Horsmanheimo
Jul 1, 1995·International Journal of Dermatology·E M Farber
Oct 1, 1995·International Journal of Dermatology·S P RaychaudhuriE M Farber
Aug 1, 1988·Acta Physiologica Scandinavica·F Lembeck
Jun 1, 2010·American Journal of Clinical Dermatology·Juliane ReuterChristoph M Schempp
Dec 3, 2014·Expert Opinion on Drug Delivery·Mahfoozur RahmanFarhan Jalees Ahmad
Mar 1, 1993·Journal of the American Academy of Dermatology·S P Raychaudhuri, E M Farber
Sep 1, 1993·Journal of the American Academy of Dermatology·C N EllisJ E Wolf
Jul 12, 2002·American Journal of Clinical Pathology·Arpad Szallasi
Sep 18, 2009·Annals of the New York Academy of Sciences·Smriti K Raychaudhuri, Siba P Raychaudhuri
Dec 7, 2010·International Journal of Dermatology·Sylvia M D GoodingEdzard Ernst
Mar 20, 2008·The American Journal of Pathology·Siba P RaychaudhuriSmriti K Raychaudhuri
Oct 20, 1998·Journal of the American Academy of Dermatology·J Y Koo
Jan 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E ChroniD Tsambaos
Jan 8, 2014·Expert Opinion on Pharmacotherapy·Andrea ChiricozziSergio Chimenti
Sep 14, 2012·Pharmaceutical Biology·Arshdeep Kaur, Suresh Kumar
Feb 22, 2008·Mediators of Inflammation·Adam Reich, Jacek C Szepietowski
Jun 29, 2016·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C ZeidlerS Ständer
Oct 3, 1999·The Journal of Investigative Dermatology·S T Hsieh, W M Lin
Feb 24, 2001·Journal of the American Academy of Dermatology·S StänderD Metze
Sep 27, 2003·The British Journal of Dermatology·G YosipovitchC L Goh
Apr 16, 2002·Experimental Dermatology·Sonja Ständer, Martin Steinhoff
May 17, 2018·Nutrition and Cancer·Annapoorna SreedharYunfeng Zhao
Jul 27, 1999·The British Journal of Dermatology·A L KrogstadB G Wallin
Jun 1, 1993·The British Journal of Dermatology·D J Eedy
Apr 18, 2007·Experimental Dermatology·Adam ReichJacek C Szepietowski
May 16, 1998·Experimental Dermatology·R W Lambert, R D Granstein
Sep 12, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xenia KodjiSusan D Brain
May 1, 1997·The Australasian Journal of Dermatology·P ArtemiS Ware

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.